Abstract
An aggressive approach to surgical resection of pulmonary metastases of bone and soft tissue sarcomas seems to extend patient survival. This therapy is most applicable to pulmonary metastases but can be considered for metastases in other sites. Criteria for appropriate selection of these patients has been outlined. However, no prospective randomized trial of surgery versus alternative therapy for these lesions has been performed. Thus, it remains unproven in a controlled clinical test that metastasectomy is beneficial. Nevertheless, there is a well-defined group of long-term survivors who are disease-free following metastasectomy. Because alternative therapy does not yield this benefit, resection of metastases in appropriately selected sarcoma patients seems warranted.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 247-250 |
| Number of pages | 4 |
| Journal | Seminars in Orthopaedics |
| Volume | 6 |
| Issue number | 4 |
| State | Published - 1991 |
Fingerprint
ASJC Scopus subject areas
- Surgery
Cite this
Resection of pulmonary metastases from primary bone and soft tissue tumors. / Goodnight Jr, James E.
In: Seminars in Orthopaedics, Vol. 6, No. 4, 1991, p. 247-250.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Resection of pulmonary metastases from primary bone and soft tissue tumors
AU - Goodnight Jr, James E
PY - 1991
Y1 - 1991
N2 - An aggressive approach to surgical resection of pulmonary metastases of bone and soft tissue sarcomas seems to extend patient survival. This therapy is most applicable to pulmonary metastases but can be considered for metastases in other sites. Criteria for appropriate selection of these patients has been outlined. However, no prospective randomized trial of surgery versus alternative therapy for these lesions has been performed. Thus, it remains unproven in a controlled clinical test that metastasectomy is beneficial. Nevertheless, there is a well-defined group of long-term survivors who are disease-free following metastasectomy. Because alternative therapy does not yield this benefit, resection of metastases in appropriately selected sarcoma patients seems warranted.
AB - An aggressive approach to surgical resection of pulmonary metastases of bone and soft tissue sarcomas seems to extend patient survival. This therapy is most applicable to pulmonary metastases but can be considered for metastases in other sites. Criteria for appropriate selection of these patients has been outlined. However, no prospective randomized trial of surgery versus alternative therapy for these lesions has been performed. Thus, it remains unproven in a controlled clinical test that metastasectomy is beneficial. Nevertheless, there is a well-defined group of long-term survivors who are disease-free following metastasectomy. Because alternative therapy does not yield this benefit, resection of metastases in appropriately selected sarcoma patients seems warranted.
UR - http://www.scopus.com/inward/record.url?scp=0026388956&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026388956&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0026388956
VL - 6
SP - 247
EP - 250
JO - Seminars in Orthopaedics
JF - Seminars in Orthopaedics
SN - 0882-052X
IS - 4
ER -